Notably, GATA3 correlates with hormone receptor (ER/PR) positivity (both 90% in our case), implicating estrogen-response pathways (e.g., ESR1/GREB1) in tumor biology (10, 21). The gene discussed is NR4A1; the disease is neoplasm.